OIF News
OIF E-Newsletter: January 2025
The January issue of the OIF E-Newsletter is here! Read updates from the OI Foundation, information about Impact Grants and the Edward D Cranston...
Edward D. Cranston College Scholarship Program
Applications are now available for the Edward D. Cranston College Scholarship 2025! This scholarship, created in honor of OI Community Member Edward D. Cranston,...
Jeanie Coleman Impact Grant Program
The Jeanie Coleman Impact Grant Program provides equipment and services that improve the quality of life for families living with OI. The program is...
2024 Accomplishments
Dear Friend, As we near the end of another wonderful year, we are taking a moment to reflect on the generosity of individuals who...
Breakthrough: July 2024
Have you read the latest issue of the OIF’s Breakthrough Newsletter? OIF National Conference Programs and Resources Fundraising Galas and Events OI Clinic Spotlight Financial...
OIF E-Newsletter: December 2024
The December issue of the OIF E-Newsletter is here! Read a letter from OIF CEO Tracy Hart, updates from the OI Foundation, OI research...
Quality of Life Findings from the IMPACT Survey!
In 2021, the Osteogenesis Imperfecta Foundation (OIF), the Osteogenesis Imperfecta Federation Europe (OIFE), and Mereo BioPharma collaborated closely to launch the IMPACT Survey. The...
Year End 2024: A Note From Our CEO
Dear Friend, On behalf of the OI Foundation Board of Directors and staff, I am proud to say that 2024 was an exceptional year...
Donor Advised Funds Support the OIF Throughout the Year!
The Osteogenesis Imperfecta Foundation would like to thank those that are making donations through their donor advised funds. Your gifts made through donor advised...
OIF E-Newsletter: November 2024
The November issue of the OIF E-Newsletter is here! Read about updates from the OIF, OI research, upcoming events, and more at https://mailchi.mp/oif/november2024.
OIF E-Newsletter: October 2024
The October issue of the OIF E-Newsletter is here! Read about Updates from the OIF, OI Research, Upcoming Events, and more at https://mailchi.mp/oif/october2024
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in OI
The OI Foundation would like to bring your attention to an update from Ultragenyx! Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis...